ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHETAN GONDHA M.D.

Internal Medicine

583

$90.4K

207
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$155
Average prescription price

Avg: $56

LAWTON DAVIS M.D.

Internal Medicine

188

$28.1K

172
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

89%
prescriptions for brand name drugs

Avg: 26%

$149
Average prescription price

Avg: $56

ALIZA LIPSON M.D.

Internal Medicine

640

$95.7K

114
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 26%

$149
Average prescription price

Avg: $56

SUNDUS LODHI M.D.

Internal Medicine

1,095

$157K

142
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$143
Average prescription price

Avg: $56

JOSEPH SMIDDY MD

Internal Medicine

3,004

$426K

133
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$142
Average prescription price

Avg: $56

JOHN PERRY M.D.

Internal Medicine

1,318

$186K

82
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$141
Average prescription price

Avg: $56

KIMBALL JOHNSON MD

Internal Medicine

1,401

$189K

86
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 26%

$135
Average prescription price

Avg: $56

GORDON WOTTON MD

Internal Medicine

2,401

$311K

283
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 26%

$130
Average prescription price

Avg: $56

JONATHAN CHEN D.O.

Internal Medicine

595

$76.3K

177
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $56

NABILA HUSSAIN M.D

Internal Medicine

2,331

$294K

121
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$126
Average prescription price

Avg: $56

HERMAN LEVY M.D.

Internal Medicine

7,494

$941K

463
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 26%

$126
Average prescription price

Avg: $56

HARSHVADAN JOSHI MD

Internal Medicine

915

$110K

78
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$121
Average prescription price

Avg: $56

GRATTAN WOODSON MD

Internal Medicine

1,375

$164K

137
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 26%

$120
Average prescription price

Avg: $56

EDWARD FREDERICKSON MD

Internal Medicine

4,298

$504K

310
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$117
Average prescription price

Avg: $56

DAVID HENDLER M.D.

Internal Medicine

1,318

$152K

91
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 26%

$116
Average prescription price

Avg: $56

ALAN STRUTH M.D.

Internal Medicine

5,120

$579K

277
192 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$113
Average prescription price

Avg: $56

DAVID MEYER M.D.

Internal Medicine

360

$40.5K

177
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $56

THOMAS TUCKER M.D.

Internal Medicine

3,616

$405K

264
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $56

ANNETTE BERNARD MD

Internal Medicine

1,938

$216K

84
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $56

SCOTT PARRY D.O.

Internal Medicine

5,166

$570K

187
93 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$110
Average prescription price

Avg: $56

JAMES WEST M.D.

Internal Medicine

3,752

$412K

271
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 26%

$110
Average prescription price

Avg: $56

SABREENA BASU M.D.

Internal Medicine

2,450

$269K

233
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 26%

$110
Average prescription price

Avg: $56

KIMBERLYNN RICHARDS M.D.

Internal Medicine

479

$52.2K

45
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

40%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $56

GREGG KOVAL M.D.

Internal Medicine

2,959

$322K

174
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $56

JASON COBB MD

Internal Medicine

1,817

$196K

170
89 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$108
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank